Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), bought 500 shares at $44.80 ($22K) on 2010-12-01, disclosed to the SEC on 2010-12-03.
Open-market purchase of $22k SLXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |